Hai Long

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Shanghai Public Health Clinical Center(Current)

Guiyang Medical University

Hai Long is an author at Shanghai Public Health Clinical Center specializing in infectious diseases, antiretroviral therapy, and antiviral pharmacotherapy.

ORCID

Publications per year

2022–2023

Publications

Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study

Lin Gan, Xiaoxin Xie, Yanhua Fu et al. · Infectious Diseases and Therapy · 2023 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study

Xuan Lv, Chaobo Zhao, Bing Song et al. · Human Vaccines & Immunotherapeutics · 2023 · 16 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17

Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice

Lin Gan, Xiaoxin Xie, Yanhua Fu et al. · Expert Review of Anti-infective Therapy · 2023 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China

Xiaoyan Yang, Yanhua Fu, Xiaoxin Xie et al. · Expert Review of Anti-infective Therapy · 2022 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–4 of 4